Vemurafenib is a pyrrolopyridine compound that functions as an inhibitor of BRAF and other kinases. It is used as an active pharmaceutical ingredient in the manufacturing of antineoplastic medications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1029872-54-5
Vemurafenib
pharmaceutical raw material
N-[3-[(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide
pharmaceutical intermediate
Trelagliptin succinate
pharmaceutical raw material
Paracetamol
pharmaceutical raw material
(R)-(7-METHYL-1,4-DIAZEPAN-1-YL)(5-METHYL-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE
pharmaceutical raw material
Suvorexant
pharmaceutical raw material
N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide
GPXBXXGIAQBQNI-UHFFFAOYSA-N
CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F